How can drug discovery for psychiatric disorders be improved?
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Psychiatric disorders such as depression, anxiety and schizophrenia are leading causes of disability worldwide, and have a huge societal impact. However, despite the clear need for better therapies, and major advances in the understanding of the molecular basis of these disorders in recent years, efforts to discover and develop new drugs for neuropsychiatric disorders, particularly those that might revolutionize disease treatment, have been relatively unsuccessful. A multidisciplinary approach will be crucial in addressing this problem, and in the first Advances in Neuroscience for Medical Innovation symposium, experts in multiple areas of neuroscience considered key questions in the field, in particular those related to the importance of neuronal plasticity. The discussions were used as a basis to propose steps that can be taken to improve the effectiveness of drug discovery for psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mechanistic heterogeneity that potentially underlies the existing classification scheme might be limiting our ability to clarify etiology and identify novel therapeutics for several psychiatric illnesses (3).”
From Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD (2012) · cites this paper as [3]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576
Self-citationDeep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Self-citationMayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Self-citationChanges in grey matter induced by training
Draganski, B., Gaser, C., Busch, V., Schuierer, G., Bogdahn, U., & May, A. (2004) · Nature · doi:10.1038/427311a · Cited by 2,373 · cited 1×
“Specific focal structural changes have been found; for example, related to visuo-spatial memory usage in London taxi-drivers and in training motor skill”
BackgroundDopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980
Self-citationLarge-scale recording of neuronal ensembles
Buzsáki, G. (2004) · Nature Neuroscience · doi:10.1038/nn1233 · Cited by 1,875
Self-citationGrace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Self-citationGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 1×
“One method that has been used, and which has provided much of the initial progress in drug design to date, is to examine the physiological and pharmacological consequences of drugs known to either mimic schizophrenia in humans (for example, PC”
MethodNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Indeed, it has been argued that if one could biopsy someone with depression, it is far from clear where one would obtain the biops”
BackgroundIntellectual ability and cortical development in children and adolescents
Shaw, P., Greenstein, D., Lerch, J., Clasen, L., Lenroot, R., Gogtay, N., Evans, A., Rapoport, J., & Giedd, J. (2006) · Nature · doi:10.1038/nature04513 · Cited by 1,543
Self-citationGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.004 · Cited by 1,397
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.014 · Cited by 1,302
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166 · cited 1×
“Functional neuroimaging provides testable strategies towards these clinical goal”
BackgroundSelf-citationDefined types of cortical interneurone structure space and spike timing in the hippocampus
Somogyi, P., & Klausberger, T. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.078915 · Cited by 927
Self-citationOrganization of cell assemblies in the hippocampus
Harris, K. D., Csicsvari, J., Hirase, H., Dragoi, G., & Buzsáki, G. (2003) · Nature · doi:10.1038/nature01834 · Cited by 884
Self-citationSomogyi, P., Tamás, G., Lujan, R., & Buhl, E. H. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00061-1 · Cited by 872
Self-citationThe Neurobiology of Slow Synaptic Transmission
Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 867
The Functional Neuroanatomy of the Placebo Effect
Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.728 · Cited by 720
Self-citationDARPP-32: An Integrator of Neurotransmission
Svenningsson, P., Nishi, A., Fisone, G., Girault, J.-A., Nairn, A. C., & Greengard, P. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121415 · Cited by 720
Self-citationGlucocorticoids, depression, and mood disorders: Structural remodeling in the brain
McEwen, B. S. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.008 · Cited by 687
Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408305102 · Cited by 614
Self-citationGating of information flow within the limbic system and the pathophysiology of schizophrenia
Grace, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00049-1 · Cited by 519
Self-citationPsychiatric endophenotypes and the development of valid animal models
Gould, T. D., & Gottesman, I. I. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00186.x · Cited by 512
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Transduction peptides: from technology to physiology
Joliot, A., & Prochiantz, A. (2004) · Nature Cell Biology · doi:10.1038/ncb0304-189 · Cited by 495
Self-citationThe phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
ANGRIST, B. M., & Gershon, S. (1970) · PubMed · Cited by 477
Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground
Weinberger, D. R., & Lipska, B. K. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00013-c · Cited by 470
Self-citationSafety of Strong, Static Magnetic Fields
Schenck, J. F. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/1522-2586(200007)12:1<2::aid-jmri2>3.0.co;2-v · Cited by 436
Charney, D. S., & Manji, H. K. (2004) · Science's STKE · doi:10.1126/stke.2252004re5 · Cited by 429
Self-citationToward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423
Self-citationTwo-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390
Calabresi, P., Gubellini, P., Centonze, D., Picconi, B., Bernardi, G., Chergui, K., Svenningsson, P., Fienberg, A. A., & Greengard, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08443.2000 · Cited by 380
Self-citationGlycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
Self-citationFitzgerald, P. B., Benitez, J., de Castella, A., Daskalakis, Z. J., Brown, T. L., & Kulkarni, J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.88 · Cited by 363
Moore, H., Jentsch, J. D., Ghajarnia, M., Geyer, M. A., & Grace, A. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.003 · Cited by 359
Self-citationLipska, B. K., Weinberger, D. R., Swerdlow, N. R., Geyer, M. A., Braff, D. L., & Jaskiw, G. E. (1995) · Psychopharmacology · doi:10.1007/bf02246439 · Cited by 357
Self-citationCannabinoids reveal importance of spike timing coordination in hippocampal function
Robbe, D., Montgomery, S. M., Thome, A., Rueda-Orozco, P. E., McNaughton, B. L., & Buzsaki, G. (2006) · Nature Neuroscience · doi:10.1038/nn1801 · Cited by 333 · cited 1×
“, and impairment of proper temporal organization might underlie the various deficits associated with psychiatric disease”
BackgroundSelf-citationDecreased Regional Brain Metabolism After ECT
Nobler, M. S., Oquendo, M. A., Kegeles, L. S., Malone, K. M., Campbell, C., Sackeim, H. A., & Mann, J. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.305 · Cited by 330
Diverse Psychotomimetics Act Through a Common Signaling Pathway
Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 314
Self-citationValjent, E., Corbillé, A.-G., Bertran-Gonzalez, J., Hervé, D., & Girault, J.-A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511030103 · Cited by 295
Self-citationLee, L., Siebner, H. R., Rowe, J. B., Rizzo, V., Rothwell, J. C., Frackowiak, R. S. J., & Friston, K. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05308.2003 · Cited by 289
Self-citationBertolino, A., Caforio, G., Blasi, G., De Candia, M., Latorre, V., Petruzzella, V., Altamura, M., Nappi, G., Papa, S., Callicott, J. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1798 · Cited by 289
Self-citationDopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs
Grace, A. A., Bunney, B. S., Moore, H., & Todd, C. L. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10064-3 · Cited by 284
Self-citationThe distribution of structural neuropathology in pre-clinical Huntington's disease
Thieben, M. J. (2002) · Brain · doi:10.1093/brain/awf179 · Cited by 272
Cohen, H., Zohar, J., Matar, M. A., Zeev, K., Loewenthal, U., & Richter-Levin, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300523 · Cited by 254
Self-citationGlucocorticoid “Programming” and PTSD Risk
SECKL, J. R., & MEANEY, M. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.027 · Cited by 234
Bonanno, G., Giambelli, R., Raiteri, L., Tiraboschi, E., Zappettini, S., Musazzi, L., Raiteri, M., Racagni, G., & Popoli, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5033-04.2005 · Cited by 234
Self-citationAvital, A., & Richter-Levin, G. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004808 · Cited by 219
Self-citationACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
(2004) · Circulation · doi:10.1161/circ.110.9.e82 · Cited by 215
Diamond, D. M., Campbell, A. M., Park, C. R., Woodson, J. C., Conrad, C. D., Bachstetter, A. D., & Mervis, R. F. (2006) · Hippocampus · doi:10.1002/hipo.20188 · Cited by 213
Self-citationFlagstad, P., Mørk, A., Glenthøj, B. Y., van Beek, J., Michael-Titus, A. T., & Didriksen, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300516 · Cited by 212
Development of dopaminergic neurons in the mammalian brain
Prakash, N., & Wurst, W. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5387-6 · Cited by 207
Origins and development of schizophrenia: Advances in experimental psychopathology.
(1998) · American Psychological Association eBooks · doi:10.1037/10305-000 · Cited by 169
Cellular Plasticity Cascades: Genes-To-Behavior Pathways in Animal Models of Bipolar Disorder
Einat, H., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.004 · Cited by 166
Self-citationGABA-A receptors: a viable target for novel anxiolytics?
Whiting, P. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.08.005 · Cited by 142
Weickert, T. W., Goldberg, T. E., Mishara, A. L., Apud, J. A., Kolachana, B. S., Egan, M. F., & Weinberger, D. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.012 · Cited by 142
Self-citationThompson, J. L., Pogue-Geile, M. F., & Grace, A. A. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007139 · Cited by 137
Self-citationCerebral Blood Flow and Mental Processes in Schizophrenia
Liddle, P. F., Friston, K. J., Frith, C. D., & Frackowiak, R. S. J. (1992) · Journal of the Royal Society of Medicine · doi:10.1177/014107689208500415 · Cited by 136
Self-citationTsoory, M., & Richter-Levin, G. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006255 · Cited by 133
Self-citationGrace, A. A. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9211-5_6 · Cited by 129
Self-citationWorking memory deficits in adult rats after prenatal disruption of neurogenesis
Gourevitch, R., Rocher, C., Pen, G. L., Krebs, M.-O., & Jay, T. M. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135703.48799.71 · Cited by 126
Loubinoux, I., Pariente, J., Boulanouar, K., Carel, C., MANELFE, C., Rascol, O., Celsis, P., & Chollet, F. (2002) · NeuroImage · doi:10.1006/nimg.2001.0957 · Cited by 125
Plasticity-Associated Gene Krox24/Zif268 Is Required for Long-Lasting Behavioral Effects of Cocaine
Valjent, E., Aubier, B., Corbillé, A.-G., Brami-Cherrier, K., Caboche, J., Topilko, P., Girault, J.-A., & Hervé, D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4601-05.2006 · Cited by 121
Self-citationNeurodevelopment and Schizophrenia
(2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735103 · Cited by 101
George, M. S., Stallings, L. E., Speer, A. M., Nahas, Z. H., SPICER, K. M., Vincent, D. J., Bohning, D. E., Cheng, K. T., Molloy, M. A., Tenebäck, C. C., et al. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199904)14:3<171::aid-hup80>3.0.co;2-7 · Cited by 91
George, M. S., Stallings, L. E., Speer, A. M., Nahas, Z., Spicer, K. M., Vincent, D. J., Bohning, D. E., Cheng, K. T., Molloy, M., Teneback, C. C., et al. (1999) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199904)14:3<161::aid-hup73>3.0.co;2-2 · Cited by 91
Ohyama, A., Hosaka, K., Komiya, Y., Akagawa, K., Yamauchi, E., Taniguchi, H., Sasagawa, N., Kumakura, K., Mochida, S., Yamauchi, T., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03342.2002 · Cited by 79
A pathophysiological paradigm for the therapy of psychiatric disease
Spedding, M., Jay, T. M., Silva, J. C. E., & Perret, L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1753 · Cited by 78
Self-citationTalbot, P. S., & Cooper, S. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301022 · Cited by 73
Diamond, D. M., Campbell, A., Park, C. R., & Vouimba, R.-M. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.09.003 · Cited by 71
Self-citationSignal Transduction and Genes-to-Behaviors Pathways in Psychiatric Diseases
Manji, H. K., Gottesman, I. I., & Gould, T. D. (2003) · Science's STKE · doi:10.1126/stke.2003.207.pe49 · Cited by 63
Self-citationGrace, A., & Moore, H. (1998) · American Psychological Association eBooks · doi:10.1037/10305-005 · Cited by 60
Self-citationGould, T. D., & Manji, H. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0502 · Cited by 55
Self-citationPharmacological actions of the antidepressant venlafaxine beyond aminergic receptors
Rossby, S. P., Manier, D. H., Liang, S., Nalepa, I., & Sulser, F. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001273 · Cited by 52
Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation
Cope, D. W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A. ‐., Oberto, A., Ogris, W., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04127.x · Cited by 39
Self-citationDevelopmental dysregulation of the dopamine system and the pathophysiology of schizophrenia
Grace, A. A. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735103.017 · Cited by 28
Self-citationHand, J. W., Lagendijk, J. J. W., Hajnal, J. V., Lau, R. W. M., & YOUNG, I. R. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/1522-2586(200007)12:1<186::aid-jmri21>3.0.co;2-2 · Cited by 23
Hofer, M. A. (2009) · Handbook of Neuroscience for the Behavioral Sciences · doi:10.1002/9780470478509.neubb001003 · Cited by 14
Research works printed but not linked: 1
- O'Donnell, P. & Grace, A. A. in Review of Psychiatry Vol 18: Schizophrenia in a Molecular Age. Ed. Tamminga, C. A. 109–140 (American Psychiatric Press, Washington DC, 1999).
Cited by
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
Self-citationSubcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.034 · Cited by 1,024
Self-citationTargeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Self-citationScaling Brain Size, Keeping Timing: Evolutionary Preservation of Brain Rhythms
Buzsáki, G., Logothetis, N., & Singer, W. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.002 · Cited by 886
Self-citationZebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
Rihel, J., Prober, D. A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S. J., Kokel, D., Rubin, L. L., Peterson, R. T., et al. (2010) · Science · doi:10.1126/science.1183090 · Cited by 778
Metadata
- Authors
- Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., Popoli, M., Prochiantz, A., Richter-Levin, G., Somogyi, P., Spedding, M., Svenningsson, P., & Weinberger, D.
- Affiliations
- Inserm (FR)
- Rutgers, The State University of New Jersey (US)
- University of South Florida (US)
- National Hospital for Neurology and Neurosurgery (GB)
- National Institutes of Health (US)
- University of Pittsburgh (US)
- University of Dundee (GB)
- Emory University (US)
- University of Milan (IT)
- Centre National de la Recherche Scientifique (FR)
- Karolinska Institutet (SE)
- Corresponding author
- Spedding, Michael
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 189-201
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2039643193
- Semantic Scholar
- 6b055b58cc82aab9331b179042a3985bb06b3e33
- Cited by
- 240
- References
- 81
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 12 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 3 · 2015: 8 · 2014: 10 · 2013: 17 · 2012: 30
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- psychiatric drug discovery, depression, schizophrenia, anxiety, neuropsychiatric disorders, neuroplasticity, translational neuroscience, multidisciplinary approach
- MeSH terms
- Mental Disorders, Consensus Statements as Topic, Humans, Models, Biological, Surveys and Questionnaires, Tranquilizing Agents, Drug Design, Signal Transduction, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.